Connecticut’s governor has signed a bill to expand a pilot program that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. The legislation sponsored by the Joint Committee on Public Health cleared the House of Representatives in 122-27 vote last month after passing the Senate by a unanimous 35-0 vote in April. Gov. Ned Lamont (D) signed it into law on Thursday. The new law builds upon an existing psychedeli…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.